Related references
Note: Only part of the references are listed.Trained innate immunity and resistance to Mycobacterium tuberculosis infection
V. A. C. M. Koeken et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
Ekta Lachmandas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy
Tariq Hussain et al.
CELLS (2019)
The Humoral Immune Response to BCG Vaccination
Rachel Tanner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Autophagy: A new strategy for host-directed therapy of tuberculosis
Seungwha Paik et al.
VIRULENCE (2019)
Ambroxol Induces Autophagy and Potentiates Rifampin Antimycobacterial Activity
Seong Won Choi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
Sheng-Wei Pan et al.
CHEST (2018)
Host-targeted therapy for tuberculosis: Time to revisit the concept
Prabha Desikan et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2018)
Mycobacterial growth inhibition is associated with trained innate immunity
Simone A. Joosten et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis
Nallely Lopez-Lopez et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2018)
Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
E. Nemes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A reappraisal on metformin
Tugba Adak et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
GM-CSF targeted immunomodulation affects host response to M-tuberculosis infection
Sulayman Benmerzoug et al.
SCIENTIFIC REPORTS (2018)
A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults
Nguyen T. H. Mai et al.
ELIFE (2018)
Mesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization
Amanda Mizukami et al.
STEM CELLS INTERNATIONAL (2018)
The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus
Ye-Jin Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
Garrett Teskey et al.
FRONTIERS IN IMMUNOLOGY (2018)
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment
Nicholas R. Degner et al.
CLINICAL INFECTIOUS DISEASES (2018)
Tuberculosis Infectiousness and Host Susceptibility
Richard D. Turner et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis
Catherine Vilcheze et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden
Chunlan Zheng et al.
GLOBAL HEALTH ACTION (2017)
Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives
Luis Pena-Quintana et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study
Chun-Wei Wu et al.
BMC PULMONARY MEDICINE (2017)
Risk of tuberculosis in patients treated with TNF-α antagonists: a systematic review and meta-analysis of randomised controlled trials
Zheng Zhang et al.
BMJ OPEN (2017)
Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with Mycobacterium tuberculosis
Qingwen Zhang et al.
FRONTIERS IN MICROBIOLOGY (2017)
The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling
Kimberly M. Sogi et al.
ACS INFECTIOUS DISEASES (2017)
Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review
Vera M. Kroesen et al.
FRONTIERS IN IMMUNOLOGY (2017)
Strategies to improve vaccine efficacy against Tuberculosis by Targeting innate immunity
Ulrich E. Schaible et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-37 Confers Protection against Mycobacterial Infection Involving Suppressing Inflammation and Modulating T Cell Activation
Haipeng Liu et al.
PLOS ONE (2017)
Clinical and Immunological Effects of rhlL-2Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis
Qi Tan et al.
SCIENTIFIC REPORTS (2017)
Protective immunity against tuberculosis: what does it look like and how do we find it?
Lu Huang et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression
Omowunmi Aibana et al.
CLINICAL INFECTIOUS DISEASES (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility
Srujitha Marupuru et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2017)
Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages
Esmeralda Juarez et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functions
Eduardo P. Amaral et al.
BMC MICROBIOLOGY (2016)
Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs
Arundhati Maitra et al.
BRITISH MEDICAL BULLETIN (2016)
Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guerin in Glucocorticoid-Treated Human Macrophages
Julia Steiger et al.
JOURNAL OF IMMUNOLOGY (2016)
Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Kohei Fujita et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T. Malherbe et al.
NATURE MEDICINE (2016)
Corticosteroids Mechanisms of Action in Health and Disease
Sivapriya Ramamoorthy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
Shunsuke Sakai et al.
PLOS PATHOGENS (2016)
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Pushpa Jayaraman et al.
PLOS PATHOGENS (2016)
Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
Selvakumar Subbian et al.
FRONTIERS IN IMMUNOLOGY (2016)
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
Selvakumar Subbian et al.
EBIOMEDICINE (2016)
Harnessing the beneficial heterologous effects of vaccination
Helen S. Goodridge et al.
NATURE REVIEWS IMMUNOLOGY (2016)
High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial
Nestan Tukvadze et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis
Mariama C. Maiga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
Hong Shen et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages
Rokeya Sultana Rekha et al.
AUTOPHAGY (2015)
Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore
Santosh B. Salunke et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
Kathleen M. Mahoney et al.
CLINICAL THERAPEUTICS (2015)
Metformin as a potential combination therapy with existing front-line antibiotics for Tuberculosis
Rohit Vashisht et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial
Peter Daley et al.
LANCET INFECTIOUS DISEASES (2015)
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness
Steven P. Cohen et al.
PAIN (2015)
High-dose vitamin D3 reduces deficiency caused by low UVB exposure and limits HIV-1 replication in urban Southern Africans
Anna K. Coussens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
Michael B. Harbut et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
Meenal Datta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Low Doses of Imatinib Induce Myelopoiesis and Enhance Host Anti-microbial Immunity
Ruth J. Napier et al.
PLOS PATHOGENS (2015)
Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3
Anna K. Coussens et al.
PLOS PATHOGENS (2015)
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis
Catherine W. M. Ong et al.
PLOS PATHOGENS (2015)
Interception of host angiogenic signalling limits mycobacterial growth
Stefan H. Oehlers et al.
NATURE (2015)
Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial
Akhirunnesa Mily et al.
PLOS ONE (2015)
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Mario Cazzola et al.
EUROPEAN RESPIRATORY REVIEW (2015)
Statins Increase Rifampin Mycobactericidal Effect
Livia Silva Lobato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Host-directed therapy of tuberculosis: what is in it for microRNA?
Marco Iannaccone et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
Ciaran Skerry et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
Suraj P. Parihar et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber et al.
NATURE (2014)
Statin therapy may prevent development of tuberculosis in diabetic state
Dibyajyoti Banerjee et al.
MEDICAL HYPOTHESES (2014)
Phagocytosis via Complement or Fc-Gamma Receptors Is Compromised in Monocytes from Type 2 Diabetes Patients with Chronic Hyperglycemia
Blanca I. Restrepo et al.
PLOS ONE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth
Sarah A. Stanley et al.
PLOS PATHOGENS (2014)
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
Aliaksandr Skrahin et al.
LANCET RESPIRATORY MEDICINE (2014)
Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'
Nawal Salahuddin et al.
BMC INFECTIOUS DISEASES (2013)
TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species
Francisco J. Roca et al.
CELL (2013)
Low-Dose Aspirin and Ibuprofen's Sterilizing Effects on Mycobacterium tuberculosis Suggest Safe New Adjuvant Therapies for Tuberculosis
Damon P. Eisen et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Ibuprofen Therapy Resulted in Significantly Decreased Tissue Bacillary Loads and Increased Survival in a New Murine Experimental Model of Active Tuberculosis
Cristina Vilaplana et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis
Julia A. Critchley et al.
LANCET INFECTIOUS DISEASES (2013)
L-arginine and Vitamin D Adjunctive Therapies in Pulmonary Tuberculosis: A Randomised, Double-Blind, Placebo-Controlled Trial
Anna P. Ralph et al.
PLOS ONE (2013)
A small jab - a big effect: nonspecific immunomodulation by vaccines
Christine S. Benn et al.
TRENDS IN IMMUNOLOGY (2013)
Clinical and Experimental Applications of Sodium Phenylbutyrate
Tommaso Iannitti et al.
Drugs in research & development (2013)
Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases
Naomi F. Walker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Host Cell Autophagy Activated by Antibiotics Is Required for Their Effective Antimycobacterial Drug Action
Jwa-Jin Kim et al.
CELL HOST & MICROBE (2012)
Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
Jennifer A. Hirst et al.
DIABETES CARE (2012)
Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients
Yuri V. Efremenko et al.
IMMUNOTHERAPY (2012)
Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
Heiko Bruns et al.
JOURNAL OF IMMUNOLOGY (2012)
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
Mamoudou Maiga et al.
PLOS ONE (2012)
Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
Johanneke Kleinnijenhuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Dynamic regulation of glucocorticoid signalling in health and disease
Simon C. Biddie et al.
RHEUMATOLOGY (2012)
Phosphodiesterase-4 Inhibition Combined with Isoniazid Treatment of Rabbits with Pulmonary Tuberculosis Reduces Macrophage Activation and Lung Pathology
Selyakumar Subbian et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
Arunasree M. Kalle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis
J. Maertzdorf et al.
GENES AND IMMUNITY (2011)
The Role of Aspirin in Childhood Tuberculous Meningitis
Johan F. Schoeman et al.
JOURNAL OF CHILD NEUROLOGY (2011)
High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial
Adrian R. Martineau et al.
LANCET (2011)
Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection
Yunfeng Ma et al.
MICROBES AND INFECTION (2011)
Co-Administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis Infected Macrophages Vaccine Induces Better Protective T Cell Memory than BCG
Vijender Singh et al.
PLOS ONE (2011)
Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
Mi-Sun Koo et al.
PLOS ONE (2011)
Dexamethasone and Long-Term Outcome of Tuberculous Meningitis in Vietnamese Adults and Adolescents
M. Estee Toeroek et al.
PLOS ONE (2011)
Control of experimental pulmonary tuberculosis depends more on immunostimulatory leukotrienes than on the absence of immunosuppressive prostaglandins
C. Peres-Buzalaf et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2011)
Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid - Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
Selvakumar Subbian et al.
PLOS PATHOGENS (2011)
Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity
Shadi Baniasadi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
Diane L. Kamen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Role of aspirin in tuberculous meningitis: A randomized open label placebo controlled trial
U. K. Misra et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
A study of cytokines in tuberculous meningitis: Clinical and MRI correlation
Usha Kant Misra et al.
NEUROSCIENCE LETTERS (2010)
Randomized controlled trial of zinc and vitamin A as co-adjuvants for the treatment of pulmonary tuberculosis
Lovett Lawson et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
Adjunctive micronutrient supplementation for pulmonary tuberculosis
Rodrigo X. Armijos et al.
SALUD PUBLICA DE MEXICO (2010)
Vitamin D as Supplementary Treatment for Tuberculosis A Double-blind, Randomized, Placebo-controlled Trial
Christian Wejse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
Jae-Min Yuk et al.
CELL HOST & MICROBE (2009)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Gold(I) Analogues of a Platinum-Acridine Antitumor Agent Are Only Moderately Cytotoxic but Show Potent Activity against Mycobacterium tuberculosis
Lauren C. Eiter et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Clifton E. Barry et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis
Justin A. Green et al.
PLOS ONE (2009)
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
Rod Dawson et al.
PLOS ONE (2009)
Cytokine therapy of tuberculosis at the crossroads
Rajko Reljic et al.
Expert Review of Respiratory Medicine (2009)
Modulating the immune response by oral zinc supplementation: a single approach for multiple diseases
Silke Overbeck et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Timothy K. Blackmore et al.
CLINICAL INFECTIOUS DISEASES (2008)
Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin
Lyudmila G. Nikolaeva et al.
CYTOKINE (2008)
Abl Kinases Regulate Autophagy by Promoting the Trafficking and Function of Lysosomal Components
Gouri Yogalingam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
Javier O. Jurado et al.
JOURNAL OF IMMUNOLOGY (2008)
A trial of the effect of micronutrient supplementation on treatment outcome, T cell counts, morbidity, and mortality in adults with pulmonary tuberculosis
Eduardo Villamor et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
Robert S. Walls
LANCET INFECTIOUS DISEASES (2008)
Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection
Eleanor Roy et al.
TUBERCULOSIS (2008)
Tuberculosis susceptibility of diabetic mice
Gregory W. Martens et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice
Noton Kumar Dutta et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence
Catherine R. Stevenson et al.
BMC PUBLIC HEALTH (2007)
Cutting edge:: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin
Philip T. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus
Chang-Hsun Hsieh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Immunosuppression during active tuberculosis is characterized by decreased interferon-γ production and CD25 expression with elevated forkhead box P3, transforming growth factor-β, and interleukin-4 mRNA levels
Teri Roberts et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice
Simona Buccheri et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis
Sean T. Byrne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The effect of multi-vitamin/mineral supplementation on mortality during treatment of pulmonary tuberculosis:: a randomised two-by-two factorial trial in Mwanza, Tanzania
N Range et al.
BRITISH JOURNAL OF NUTRITION (2006)
Activation of AMP-activated protein kinase reduces hyperglycemia-Induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells
D Kukidome et al.
DIABETES (2006)
Mycobacterium tuberculosis -: Induced cytokine and chemokine expression by human microglia and astrocytes:: Effects of dexamethasone
RB Rock et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effects of dexamethasone and transient malnutrition on rabbits infected with aerosolized Mycobacterium tuberculosis CDC1551
AK Kesavan et al.
INFECTION AND IMMUNITY (2005)
Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs
KI Happel et al.
INFECTION AND IMMUNITY (2005)
Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production
A Bafica et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: A phase 2 clinical trial in Uganda
H Mayanja-Kizza et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effect of neutralizing transforming growth factor β1 on the immune response against Mycobacterium tuberculosis in guinea pigs
SS Allen et al.
INFECTION AND IMMUNITY (2004)
Adjuvant interferon gamma in patients with drug-resistant pulmonary tuberculosis:: a pilot study -: art. no. 44
R Suárez-Méndez et al.
BMC INFECTIOUS DISEASES (2004)
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults
GE Thwaites et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus Calmette-Guerin vaccination
M Umemura et al.
INFECTION AND IMMUNITY (2003)
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis
JL Johnson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
T Schön et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Dexamethasone in adults with bacterial meningitis.
J de Gans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis
JM Moreno et al.
IMMUNOLOGY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Blocking the receptor for IL-10 improves antimycobacterial chemotherapy and vaccination
RA Silva et al.
JOURNAL OF IMMUNOLOGY (2001)
Interleukin-12 as successful adjuvant in tuberculosis treatment
U Greinert et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations
C Kyrklund et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Isoniazid- and rifampicin-induced oxidative hepatic injury -: protection by N-acetylcysteine
S Attri et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2000)
Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients
JG Hakim et al.
HEART (2000)
Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice
MJ Maeurer et al.
INFECTION AND IMMUNITY (2000)
Share Paper
